Company Filing History:
2 out of 169 
1 out of 2,119 
Years Active: 2012-2014
Title: Ehud Zigmond: Innovator in Proliferative Disorder Treatments
Introduction
Ehud Zigmond is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of medical research, particularly in the treatment of proliferative disorders. With a total of 2 patents, his work focuses on innovative methods for inhibiting tumor cell proliferation.
Latest Patents
Zigmond's latest patents revolve around the inhibition of ornithine aminotransferase (OAT) for the treatment of proliferative disorders. His inventions detail methods for suppressing tumor cell proliferation through the selective inhibition of OAT. Specifically, he explores the use of OAT inhibitors, such as 5-amino-1,3-hexadienyl-carboxylic acid (Gabaculine) and its analogue, for treating conditions like hepatocellular carcinoma. Additionally, his patents provide methods and kits for diagnosing pathologic proliferative disorders by determining the level of OAT expressed in biological samples from subjects.
Career Highlights
Throughout his career, Zigmond has worked with esteemed organizations, including Hadasit Medical Research Services and Development Ltd. and Northwestern University. His experience in these institutions has contributed to his expertise in medical research and innovation.
Collaborations
Zigmond has collaborated with notable individuals in his field, including Yaron Ilan and Richard B. Silverman. These partnerships have likely enhanced his research and development efforts.
Conclusion
Ehud Zigmond's contributions to the treatment of proliferative disorders through his innovative patents highlight his role as a significant figure in medical research. His work continues to pave the way for advancements in the diagnosis and treatment of serious health conditions.